NCT01010217 2020-03-25Mismatched Transplantation Using High-dose Post-transplant CyclophosphamideM.D. Anderson Cancer CenterPhase 2 Completed176 enrolled 18 charts
NCT02855359 2019-03-11Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular LymphomaSeagen Inc.Phase 2 Terminated24 enrolled 10 charts
NCT01925612 2018-06-21Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)Seagen Inc.Phase 2 Terminated87 enrolled 18 charts
NCT01220297 2017-06-05Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCTStanford UniversityPhase 2 Terminated3 enrolled 13 charts
NCT00800839 2016-09-19Busulfan and Fludarabine Followed by Post-transplant CyclophosphamideM.D. Anderson Cancer CenterPhase 2 Completed56 enrolled 10 charts